Get started
Author

Michał Marczyk

Observed names: M Marczyk, M. Marczyk, Marczyk, Michal, Marczyk, Michał, Michal Marczyk, Michał MARCZYK
Observed institutions: Silesian University of Technology, The University of Texas MD Anderson Cancer Center, Howard Hughes Medical Institute, Stockholm University, Yale Cancer Center, Yale University, The Maria Sklodowska-Curie National Research Institute of Oncology, Charité - Universitätsmedizin Berlin
ORCID: 0000-0003-2508-5736
Observed ORCID: 0000-0003-2508-5736
OpenAlex ID: A5087940597
Gene set enrichment for reproducible science: comparison of CERNO and eight other algorithms
2019 · Joanna Zyla, Michal Marczyk, et al. · Bioinformatics · 122
PDF
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden
2020 · Tao Qing, Hussein Mohsen, et al. · Nature Communications · 112
PDF
Ranking metrics in gene set enrichment analysis: do they matter?
2017 · Joanna Zyla, Michal Marczyk, et al. · BMC Bioinformatics · 77
PDF
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
2021 · Julia Foldi, Andrea Silber, et al. · npj Breast Cancer · 71
PDF
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry†
2017 · Robert Dziedzic, Wojciech Żurek, et al. · European Journal of Cardio-Thoracic Surgery · 71
Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer
2016 · Maciej Bobowicz, Marcin Skrzypski, et al. · Clinical & Experimental Metastasis · 64
PDF
Serum lipid profile discriminates patients with early lung cancer from healthy controls
2017 · Małgorzata Ros-Mazurczyk, Karol Jelonek, et al. · Lung Cancer · 61
The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues
2019 · Michal Marczyk, Chunxiao Fu, et al. · BMC Cancer · 60
PDF
Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers
2020 · Tess O’Meara, Michal Marczyk, et al. · JCO Precision Oncology · 53
Adaptive filtering of microarray gene expression data based on Gaussian mixture decomposition
2013 · Michal Marczyk, Roman Jaksik, et al. · BMC Bioinformatics · 49
PDF
Signal Partitioning Algorithm for Highly Efficient Gaussian Mixture Modeling in Mass Spectrometry
2015 · Andrzej Polanski, Michal Marczyk, et al. · PLoS ONE · 41
PDF
Radiation-Induced Changes in Serum Lipidome of Head and Neck Cancer Patients
2014 · Karol Jelonek, Monika Pietrowska, et al. · International Journal of Molecular Sciences · 39
PDF
Diverse immune response of DNA damage repair-deficient tumors
2021 · Tao Qing, Tomi Jun, et al. · Cell Reports Medicine · 38
PDF
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
2022 · Tao Qing, Thomas Karn, et al. · npj Breast Cancer · 31
PDF
Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
2021 · Gauri A. Patwardhan, Michal Marczyk, et al. · npj Breast Cancer · 31
PDF
Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools
2019 · Julia Foldi, Tess O’Meara, et al. · Journal of Clinical Oncology · 28
Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer
2020 · Kimi Drobin, Michal Marczyk, et al. · Cancers · 27
PDF
Serum mass profile signature as a biomarker of early lung cancer
2016 · Piotr Widlak, Monika Pietrowska, et al. · Lung Cancer · 26
BatchI: Batch effect Identification in high-throughput screening data using a dynamic programming algorithm
2018 · Anna Papiez, Michal Marczyk, et al. · Bioinformatics · 25
PDF
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer
2022 · Michal Marczyk, Tao Qing, et al. · npj Breast Cancer · 24
PDF
Influence of genetic background and oxidative stress response on risk of mandibular osteoradionecrosis after radiotherapy of head and neck cancer
2014 · Daniel Danielsson, Karl Brehwens, et al. · Head & Neck · 23
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
2024 · Carsten Denkert, Andreas Schneeweiss, et al. · Cell Reports Medicine · 22
Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials
2022 · M. Marczyk, A. Mrukwa, et al. · Annals of Oncology · 21
PDF
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells
2020 · Michal Marczyk, Gauri A. Patwardhan, et al. · Cancers · 21
PDF
Initializing the EM Algorithm for Univariate Gaussian, Multi-Component, Heteroscedastic Mixture Models by Dynamic Programming Partitions
2017 · Andrzej Polanski, Michal Marczyk, et al. · International Journal of Computational Methods · 18
PDF
Works count: 243
Citation count: 1,541
H-index: 22
I10-index: 40
Year
Topic
Type